University of Colorado, Denver
This study will study the feasibility of using multi-cancer early detection (MCED) testing in individuals at high risk for cancer development. We will look at participants to have germline mutations in cancer associated genes and participants who have pancreatic cysts. Participants will undergo testing and complete questionnaires to evaluating anxiety and adherence to standard screening after testing.
This study is evaluating the feasibility of using multi-cancer early detection (MCED) testing in individuals at high risk for cancer development. This will be done in two high risk populations. Participants with pathogenic or likely pathogenic germline mutations associated with moderate to high penetrance for cancer development (Cohort A) and those with high-risk pancreatic cysts (Cohort B). Eligible participants will undergo testing and complete questionnaires to evaluating anxiety and adherence to standard screening after testing.
Inclusion Criteria: * Provision to sign and date the consent form. Patients will be offered an electronic consent via REDCap, or they may use a paper copy. * Stated willingness to comply with all study procedures and be available for the duration of the study. * Be an adult aged 40 years or older. * Individuals will be eligible to enroll into Cohort A if they are being evaluated within the University of Colorado's Hereditary Cancer Clinic and have a known germline pathogenic or likely pathogenic germline mutation of any of the following genes: * BRCA 1, BRCA 2, PALB2, MLH 1, MSH 2, MSH 6, ATM…
Patients who decide to enroll will undergo a blood draw to complete the Galleri MCED test and banking for future research, along with baseline sociodemographic, anxiety, cancer screening adherence, and cancer history questionnaires. After completing Galleri testing and receiving the results, patients will be directed to the cancer diagnostics clinic at AMC if they have a positive result. All patients will complete repeat anxiety, cancer history, and cancer screening adherence questionnaires at the 1-year and 2-year timepoints.
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.